Finance

Beta
Lists
002252:SHE
Shanghai RAAS Blood Products Co Ltd
CNÂ¥5.24
-0.19%
(-0.010) 1D
Jun 3, 3:04:06 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002252...
Open
CNÂ¥5.25
High
CNÂ¥5.28
Low
CNÂ¥5.20
Mkt. cap
35.25B
Avg. vol.
29.89M
Volume
26.26M
P/E ratio
26.13
52-wk high
CNÂ¥7.26
52-wk low
CNÂ¥5.13
EPS
CNÂ¥0.20
Shares outstanding
6.64B
No. of employees
4K
Open
CNÂ¥5.25
High
CNÂ¥5.28
Low
CNÂ¥5.20
Mkt. cap
35.25B
Avg. vol.
29.89M
Volume
26.26M
P/E ratio
26.13
52-wk high
CNÂ¥7.26
52-wk low
CNÂ¥5.13
EPS
CNÂ¥0.20
Shares outstanding
6.64B
No. of employees
4K
News stories
From sources across the web
About Shanghai RAAS Blood Products Co Ltd
CEO-
Employees4.04K
FoundedOct 29, 1988
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.95B
2.14B
1.26B
1.51B
Cost of goods sold
1.25B
1.35B
828.13M
942.79M
Cost of revenue
1.25B
1.35B
828.13M
942.79M
Research and development expenses
68.20M
48.32M
73.79M
44.42M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
168.51M
236.38M
241.85M
182.57M
Operating expense
264.37M
307.00M
308.55M
241.16M
Total operating expenses
1.52B
1.66B
1.14B
1.18B
Operating income
429.94M
482.77M
120.45M
325.54M
Other non operating income
-2.84M
11.10M
-21.93M
917.46K
EBT including unusual items
539.45M
513.97M
181.81M
375.95M
EBT excluding unusual items
542.65M
567.01M
191.26M
381.36M
Income tax expense
76.02M
73.31M
75.53M
60.12M
Effective tax rate
14.09%
14.26%
41.55%
15.99%
Other operating expenses
14.23M
7.61M
16.06M
13.04M
Net income
463.81M
440.85M
106.27M
315.83M
Net profit margin
23.83%
20.61%
8.45%
20.92%
Earnings per share
0.07
0.06
0.02
-
Interest and investment income
123.02M
88.78M
96.72M
9.88M
Interest expense
-5.75M
-17.35M
-20.78M
-20.81M
Net interest expenses
117.27M
71.43M
75.95M
-10.93M
Depreciation and amortization charges
-
-
-
-
EBITDA
477.82M
532.66M
175.88M
380.96M
Gain or loss from assets sale
-48.61K
48.61K
-21.16M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more